Exploring the Evolving Role of HER2 for the Treatment of Gynecologic Cancers

The role of HER2 in gynecologic cancers is evolving-are you up to speed? Don't miss this live, expert-led session where we will dive into guideline-aligned strategies for HER2 testing, the latest clinical evidence, and personalized treatment planning. Gain important insights, including: The prevalence and relevance of HER2 overexpression in ovarian, endometrial, and cervical cancers Best practices for HER2 testing to ensure accurate identification of patients with HER2 overexpressing tumors The latest clinical data on HER2-directed therapies and their impact on personalized treatment. Stay ahead of the latest advancements and bring back valuable insights to your clinical practice!